Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.

NCT03541083 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

71

Enrollment

OTHER

Sponsor class

Conditions

ALL, Adult

Interventions

DRUG: Blinatumomab

Sponsor

Stichting Hemato-Oncologie voor Volwassenen Nederland